R
3.82
-0.21 (-5.21%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Recursion Pharmaceuticals, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.4 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | 2.0 |
| 相对估值 | NA |
| 财务健康 | 0.0 |
| 宏观环境 | -2.8 |
| AI Insight | NA |
| AI Technical | NA |
| 平均 | -0.40 |
|
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 4.78% |
| 机构持股比例 | 69.39% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Mic Capital Management Uk Llp | 30 Jun 2026 | 9,644,033 |
该时间范围内无数据。
该时间范围内无数据。
投资组合